Replacement of conventional doxorubicin by pegylated liposomal doxorubicin is a safe and effective alternative in the treatment of non-Hodgkin's lymphoma patients with cardiac risk factors
| Image |  |
|---|---|
| Description | scientific article published on August 18, 2011 |
| Author/s |
author: Mathias Witzens-Harig |
| Publication date | August 18, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
http://link.springer.com/content/pdf/10.1007/s00277-011-1308-y.pdf |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |